10x Genomics财报电话会议：耗材业务亮眼，资本支出承压 - TipRanks
10x Genomics Earnings Call: Consumables Shine, CapEx Bites - TipRanks
生命科学资讯
生物技术与制药领域的最新动态
龙沙集团股价复苏：这家瑞士CDMO巨头是否重回正轨？——特别报道
Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS
龙沙集团股价复苏：这家瑞士CDMO巨头是否重回正轨？——特别报道
Lonza’s Stock In Recovery Mode: Is This Swiss CDMO Finally Back On Track? - AD HOC NEWS
安捷伦科技(A)的看涨前景可能因新PD-L1测试获批及股息消息而改变 - simplywall.st
The Bull Case For Agilent Technologies (A) Could Change Following New PD-L1 Test Approval And Dividend News - simplywall.st
Moderna与FDA之争；赛诺菲CEO保罗·哈德森离职；临床试验为何如此昂贵；及其他动态
Moderna vs FDA; Paul Hudson out at Sanofi; Why clinical trials are so costly; and more
安捷伦科技公司$A股被荷兰国际集团减持 - MarketBeat
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat
赛默飞世尔科技宣布发行38亿美元高级票据 - GuruFocus
Thermo Fisher Scientific (TMO) Announces $3.8 Billion Senior Not - GuruFocus
Assetmark Inc. 增持安捷伦科技公司股份 $A - MarketBeat
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
Illumina（纳斯达克：ILMN）获华尔街禅升级为强力买入评级——MarketBeat
Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
10X Genomics面临多重风险：业绩指引不明、股价波动及融资挑战——TipRanks分析
Risk Factors Weigh on 10X Genomics: Uncertain Guidance, Stock Volatility, and Capital-Raising Challenges - TipRanks
解码10x Genomics公司（TXG）：战略SWOT深度分析 - GuruFocus
Decoding 10x Genomics Inc (TXG): A Strategic SWOT Insight - GuruFocus
10x Genomics (TXG) 亏损收窄挑战看跌盈利预期
Shrinking TTM Loss At 10x Genomics (TXG) Tests Bearish Earnings Narratives - simplywall.st
10x Genomics (TXG) 亏损收窄挑战看跌财报叙事 - simplywall.st
Shrinking TTM Loss At 10x Genomics (TXG) Tests Bearish Earnings Narratives - simplywall.st
'对患者来说，这确实是艰难时刻'：Biohaven首席执行官称FDA繁文缛节阻碍罕见病治疗药物获取
'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments
尽管有局长优惠券，FDA仍拒绝批准Disc公司的罕见病药物。
FDA rejects Disc's rare disease drug despite commissioner's voucher
从样本到洞见：利用Illumina五碱基解决方案简化分析流程
From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina
Illumina完成从Standard BioTools收购SomaLogic的交易 - BizWest
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
专家展望：十位分析师眼中的10x Genomics公司——Benzinga视角
Expert Outlook: 10x Genomics Through The Eyes Of 10 Analysts - Benzinga
随着FDA对Moderna的决定，疫苗制造商面临日益不确定的监管环境
With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FDA批准Encora Therapeutics可穿戴腕部设备用于治疗特发性震颤。
FDA clears Encora Therapeutics’ wearable wrist device for essential tremor